STOCK TITAN

scPharmaceuticals Inc. to Participate in the Maxim Group LLC Late-Stage Advancements in Heart Failure Therapeutics and Management Panel Discussion

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

scPharmaceuticals Inc. (Nasdaq: SCPH) announced that CEO John Tucker will participate in a panel discussion on heart failure therapeutics on July 14, 2022, at 10:00 a.m. ET. The event is hosted by Maxim Group LLC and will be available live on M-Vest. The company is dedicated to developing products that enhance infused therapy delivery, improve patient care, and lower healthcare costs. Their focus includes self-administered IV-strength treatments for heart failure and infectious diseases.

Positive
  • None.
Negative
  • None.

BURLINGTON, Mass., July 13, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, announced today that John Tucker, president & chief executive officer, is scheduled to participate in the Late-Stage Advancements in Heart Failure Therapeutics and Management panel discussion, presented by Maxim Group LLC and hosted by M-Vest, on Thursday, July 14th, 2022 at 10:00 a.m. ET. 

This conference will be live on M-Vest. Click Here to Reserve your seat.

About scPharmaceuticals

scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.

Katherine Taudvin
scPharmaceuticals Inc., 781-301-6706
ktaudvin@scpharma.com

Investors:
Hans Vitzthum
LifeSci Advisors, 617-430-7578
hans@lifesciadvisors.com


FAQ

What is the date and time of the scPharmaceuticals panel discussion?

The panel discussion featuring scPharmaceuticals CEO John Tucker is scheduled for July 14, 2022, at 10:00 a.m. ET.

Where will the scPharmaceuticals panel discussion be held?

The panel discussion will be hosted live on M-Vest.

Who is participating in the panel discussion on heart failure therapies?

John Tucker, the president and CEO of scPharmaceuticals, will participate in the panel discussion.

What is the focus of scPharmaceuticals' products?

scPharmaceuticals focuses on developing products that optimize the delivery of infused therapies and reduce healthcare costs.

What are the lead programs of scPharmaceuticals?

scPharmaceuticals' lead programs focus on the subcutaneous self-administration of IV-strength treatments in heart failure and infectious diseases.

scPharmaceuticals Inc.

NASDAQ:SCPH

SCPH Rankings

SCPH Latest News

SCPH Stock Data

165.13M
35.58M
10.68%
81.66%
10.92%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
BURLINGTON